112 related articles for article (PubMed ID: 27164542)
1. A novel liposomal recombinant lipoimmunogen enhances anti-tumor immunity.
Shen KY; Liu HY; Li HJ; Wu CC; Liou GG; Chang YC; Leng CH; Liu SJ
J Control Release; 2016 Jul; 233():57-63. PubMed ID: 27164542
[TBL] [Abstract][Full Text] [Related]
2. Reactive oxygen species play a central role in the activity of cationic liposome based cancer vaccine.
Yan W; Chen W; Huang L
J Control Release; 2008 Aug; 130(1):22-8. PubMed ID: 18554742
[TBL] [Abstract][Full Text] [Related]
3. The effects of salt on the physicochemical properties and immunogenicity of protein based vaccine formulated in cationic liposome.
Yan W; Huang L
Int J Pharm; 2009 Feb; 368(1-2):56-62. PubMed ID: 18992312
[TBL] [Abstract][Full Text] [Related]
4. Enantiospecific adjuvant activity of cationic lipid DOTAP in cancer vaccine.
Vasievich EA; Chen W; Huang L
Cancer Immunol Immunother; 2011 May; 60(5):629-38. PubMed ID: 21267720
[TBL] [Abstract][Full Text] [Related]
5. A simple but effective cancer vaccine consisting of an antigen and a cationic lipid.
Chen W; Yan W; Huang L
Cancer Immunol Immunother; 2008 Apr; 57(4):517-30. PubMed ID: 17724588
[TBL] [Abstract][Full Text] [Related]
6. Attachment of class B CpG ODN onto DOTAP/DC-chol liposome in nasal vaccine formulations augments antigen-specific immune responses in mice.
Tada R; Muto S; Iwata T; Hidaka A; Kiyono H; Kunisawa J; Aramaki Y
BMC Res Notes; 2017 Jan; 10(1):68. PubMed ID: 28126014
[TBL] [Abstract][Full Text] [Related]
7. Toll-like receptor 3 agonist complexed with cationic liposome augments vaccine-elicited antitumor immunity by enhancing TLR3-IRF3 signaling and type I interferons in dendritic cells.
Wang C; Zhuang Y; Zhang Y; Luo Z; Gao N; Li P; Pan H; Cai L; Ma Y
Vaccine; 2012 Jul; 30(32):4790-9. PubMed ID: 22634298
[TBL] [Abstract][Full Text] [Related]
8. Liposomal TLR9 Agonist Combined with TLR2 Agonist-Fused Antigen Can Modulate Tumor Microenvironment through Dendritic Cells.
Shen KY; Liu HY; Yan WL; Wu CC; Lee MH; Leng CH; Liu SJ
Cancers (Basel); 2020 Mar; 12(4):. PubMed ID: 32231003
[TBL] [Abstract][Full Text] [Related]
9. PEGylated cationic liposomes robustly augment vaccine-induced immune responses: Role of lymphatic trafficking and biodistribution.
Zhuang Y; Ma Y; Wang C; Hai L; Yan C; Zhang Y; Liu F; Cai L
J Control Release; 2012 Apr; 159(1):135-42. PubMed ID: 22226776
[TBL] [Abstract][Full Text] [Related]
10. Effective induction of anti-tumor immunity using p5 HER-2/neu derived peptide encapsulated in fusogenic DOTAP cationic liposomes co-administrated with CpG-ODN.
Mansourian M; Badiee A; Jalali SA; Shariat S; Yazdani M; Amin M; Jaafari MR
Immunol Lett; 2014 Nov; 162(1 Pt A):87-93. PubMed ID: 25086399
[TBL] [Abstract][Full Text] [Related]
11. Induction of cytotoxic T-lymphocytes and antitumor activity by a liposomal lipopeptide vaccine.
Chen W; Huang L
Mol Pharm; 2008; 5(3):464-71. PubMed ID: 18266319
[TBL] [Abstract][Full Text] [Related]
12. Poly (I:C)-DOTAP cationic nanoliposome containing multi-epitope HER2-derived peptide promotes vaccine-elicited anti-tumor immunity in a murine model.
Alipour Talesh G; Ebrahimi Z; Badiee A; Mansourian M; Attar H; Arabi L; Jalali SA; Jaafari MR
Immunol Lett; 2016 Aug; 176():57-64. PubMed ID: 27260485
[TBL] [Abstract][Full Text] [Related]
13. Intranasal Immunization with DOTAP Cationic Liposomes Combined with DC-Cholesterol Induces Potent Antigen-Specific Mucosal and Systemic Immune Responses in Mice.
Tada R; Hidaka A; Iwase N; Takahashi S; Yamakita Y; Iwata T; Muto S; Sato E; Takayama N; Honjo E; Kiyono H; Kunisawa J; Aramaki Y
PLoS One; 2015; 10(10):e0139785. PubMed ID: 26440657
[TBL] [Abstract][Full Text] [Related]
14. Cell cytotoxicity, immunostimulatory and antitumor effects of lipid content of liposomal delivery platforms in cancer immunotherapies. A comprehensive in-vivo and in-vitro study.
Nikpoor AR; Jaafari MR; Zamani P; Teymouri M; Gouklani H; Saburi E; Darban SA; Badiee A; Bahramifar A; Fasihi-Ramandi M; Taheri RA
Int J Pharm; 2019 Aug; 567():118492. PubMed ID: 31271815
[TBL] [Abstract][Full Text] [Related]
15. Mechanism of adjuvant activity of cationic liposome: phosphorylation of a MAP kinase, ERK and induction of chemokines.
Yan W; Chen W; Huang L
Mol Immunol; 2007 Jul; 44(15):3672-81. PubMed ID: 17521728
[TBL] [Abstract][Full Text] [Related]
16. Intranasal delivery of cationic liposome-protamine complex mRNA vaccine elicits effective anti-tumor immunity.
Mai Y; Guo J; Zhao Y; Ma S; Hou Y; Yang J
Cell Immunol; 2020 Aug; 354():104143. PubMed ID: 32563850
[TBL] [Abstract][Full Text] [Related]
17. Trp2 peptide vaccine adjuvanted with (R)-DOTAP inhibits tumor growth in an advanced melanoma model.
Vasievich EA; Ramishetti S; Zhang Y; Huang L
Mol Pharm; 2012 Feb; 9(2):261-8. PubMed ID: 22142394
[TBL] [Abstract][Full Text] [Related]
18. Cationic liposome-hyaluronic acid hybrid nanoparticles for intranasal vaccination with subunit antigens.
Fan Y; Sahdev P; Ochyl LJ; Akerberg J; Moon JJ
J Control Release; 2015 Jun; 208():121-129. PubMed ID: 25869965
[TBL] [Abstract][Full Text] [Related]
19. Cationic liposomes loaded with a synthetic long peptide and poly(I:C): a defined adjuvanted vaccine for induction of antigen-specific T cell cytotoxicity.
Varypataki EM; van der Maaden K; Bouwstra J; Ossendorp F; Jiskoot W
AAPS J; 2015 Jan; 17(1):216-26. PubMed ID: 25387996
[TBL] [Abstract][Full Text] [Related]
20. Antigen Priming with Enantiospecific Cationic Lipid Nanoparticles Induces Potent Antitumor CTL Responses through Novel Induction of a Type I IFN Response.
Gandhapudi SK; Ward M; Bush JPC; Bedu-Addo F; Conn G; Woodward JG
J Immunol; 2019 Jun; 202(12):3524-3536. PubMed ID: 31053626
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
